San Francisco Bay Area biotech stories.
Sunday, December 5, 2010
Cancer study boosts Genentech's Rituxan
Some blood cancer patients could use Genentech Inc.’s venerable drug Rituxan earlier to hold the cancer at bay and even shrink tumors.
Share to Twitter
Share to Facebook
Share to Pinterest
Post a Comment
Post Comments (Atom)